Primary Retinal Dysplasia (PRD) (Middle Region) Antikörper
Kurzübersicht für Primary Retinal Dysplasia (PRD) (Middle Region) Antikörper (ABIN631772)
Target
Alle Primary Retinal Dysplasia (PRD) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- PRD antibody was raised against the middle region of PRD
-
Aufreinigung
- Affinity purified
-
Immunogen
- PRD antibody was raised using the middle region of PRD corresponding to a region with amino acids MTVTAFAAAMHRPFFNGYSTMQDMNSGQGRVNQLGGVFINGRPLPNNIRL
-
-
-
-
Applikationshinweise
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
PRD Blocking Peptide, (ABIN5615532), is also available for use as a blocking control in assays to test for specificity of this PRD antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PRD antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Primary Retinal Dysplasia (PRD)
-
Andere Bezeichnung
- PRD
-
Hintergrund
- Prd is a pair-rule protein expressed in a segmentally repeating pattern to define the polarity of embryonic segments.
-
Molekulargewicht
- 65 kDa (MW of target protein)
Target
-